Zymeworks (ZYME) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NYSE: ZYME) reported Q3 EPS of ($0.66), $0.23 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $5.55 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eaton (ETN) Tops Q3 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance
- Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c; Offers Guidance
- BETA Technologies, Inc. (BETA) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
